Literature DB >> 23995660

Using Galleria mellonella-Candida albicans infection model to evaluate antifungal agents.

De-Dong Li1, Li Deng, Gan-Hai Hu, Lan-Xue Zhao, Dan-Dan Hu, Yuan-Ying Jiang, Yan Wang.   

Abstract

Candida albicans is the most common fungal pathogen. Galleria mellonella is widely used as an infection model host. Nevertheless, the G. mellonella-C. albicans infection model had not been optimized for drug evaluation before this study. In this work, we revealed that 5 × 10(5) colony forming unit (CFU)/larva was a suitable inoculum to optimize the G. mellonella-C. albicans infection model in order to evaluate antifungal agents. Using our optimized model, the antifungal effect of fluconazole, amphotericin B and flucytosine, and the synergy between amphotericin B and flucytosine were successfully verified. Thus, this study provides a rapid, inexpensive and reliable way to evaluate antifungals in vivo.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23995660     DOI: 10.1248/bpb.b13-00270

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  28 in total

1.  Galleria mellonella Larvae as an Infection Model for Penicillium marneffei.

Authors:  Xiaowen Huang; Dedong Li; Liyan Xi; Eleftherios Mylonakis
Journal:  Mycopathologia       Date:  2015-05-24       Impact factor: 2.574

2.  The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.

Authors:  Marçal Mariné; Vinicius Leite Pedro Bom; Patricia Alves de Castro; Lizziane Kretli Winkelstroter; Leandra Naira Ramalho; Neil Andrew Brown; Gustavo Henrique Goldman
Journal:  Virulence       Date:  2015-03-09       Impact factor: 5.882

3.  Establishment and Validation of Galleria mellonella as a Novel Model Organism To Study Mycobacterium abscessus Infection, Pathogenesis, and Treatment.

Authors:  Michal Meir; Tatyana Grosfeld; Daniel Barkan
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

4.  Adaptation of a Gaussia princeps Luciferase reporter system in Candida albicans for in vivo detection in the Galleria mellonella infection model.

Authors:  Eric Delarze; Françoise Ischer; Dominique Sanglard; Alix T Coste
Journal:  Virulence       Date:  2015       Impact factor: 5.882

5.  Fluconazole Pharmacokinetics in Galleria mellonella Larvae and Performance Evaluation of a Bioassay Compared to Liquid Chromatography-Tandem Mass Spectrometry for Hemolymph Specimens.

Authors:  Karen Marie Thyssen Astvad; Joseph Meletiadis; Sarah Whalley; Maiken Cavling Arendrup
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

6.  Implications of the EUCAST Trailing Phenomenon in Candida tropicalis for the In Vivo Susceptibility in Invertebrate and Murine Models.

Authors:  K M T Astvad; D Sanglard; E Delarze; R K Hare; M C Arendrup
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

7.  Contribution of Fdh3 and Glr1 to Glutathione Redox State, Stress Adaptation and Virulence in Candida albicans.

Authors:  Anna T Tillmann; Karin Strijbis; Gary Cameron; Elahe Radmaneshfar; Marco Thiel; Carol A Munro; Donna M MacCallum; Ben Distel; Neil A R Gow; Alistair J P Brown
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

8.  Galleria mellonella as a model host to study virulence of Candida.

Authors:  Ilse D Jacobsen
Journal:  Virulence       Date:  2014-01-02       Impact factor: 5.882

9.  A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents.

Authors:  Luciano Polonelli; Tecla Ciociola; Lisa Elviri; Pier Paolo Zanello; Laura Giovati; Denise C Arruda; Julián E Muñoz; Renato A Mortara; Giulia Morace; Elisa Borghi; Serena Galati; Oriano Marin; Claudio Casoli; Elisabetta Pilotti; Paola Ronzi; Luiz R Travassos; Walter Magliani; Stefania Conti
Journal:  Sci Rep       Date:  2016-10-11       Impact factor: 4.379

10.  Antifungal Effect of Novel 2-Bromo-2-Chloro-2-(4-Chlorophenylsulfonyl)-1-Phenylethanone against Candida Strains.

Authors:  Monika Staniszewska; Małgorzata Bondaryk; Magdalena Wieczorek; Eine Estrada-Mata; Héctor M Mora-Montes; Zbigniew Ochal
Journal:  Front Microbiol       Date:  2016-08-25       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.